Showing results (91-100 of 157) with videos related to
Sort By:
Pageof 16
Journal of Affective Disorders|August 9, 2023
Clinical efficacy and safety of Zuranolone (SAGE-217) in individuals with major depressive disorderShakila Meshkat, Kayla M Teopiz, Joshua D Di Vincenzo, et al.Annals of General Psychiatry|November 11, 2024
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) as treatment for nicotine cessation in psychiatric populations: a systematic reviewSerene Lee, Maggie Li, Gia Han Le, et al.Journal of Affective Disorders|November 8, 2024
A systematic review in effects of glucagon-like peptide-1 (GLP-1) mono-agonists on functional connectivity: Target engagement and rationale for the development in mental disordersHezekiah C T Au, Yang Jing Zheng, Gia Han Le, et al.Bipolar Disorders|August 14, 2025
The Efficacy of Pharmacological Interventions in the Treatment of Major Depressive Disorder and Bipolar Depression With Mixed Features: A Systematic ReviewNaomi Xiao, Liyang Yin, Serene Lee, et al.Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|October 25, 2022
Ketamine as potential treatment for postpartum depression: A narrative reviewDavid Chen-Li, Leanna M W Lui, Joshua D Rosenblat, et al.Journal of Affective Disorders|September 1, 2022
The association between stage of treatment-resistant depression and clinical utility of ketamine/esketamine: A systematic reviewAnastasia Levinta, Shakila Meshkat, Roger S McIntyre, et al.Journal of Affective Disorders|July 17, 2024
Preclinical and clinical efficacy of kappa opioid receptor antagonists for depression: A systematic reviewSabrina Wong, Gia Han Le, Shreya Vasudeva, et al.Acta Neuropsychiatrica|February 13, 2026
The Effect of GLP-1 Receptor Agonists on Autophagy: Insights Gathered from Research Evaluating Neurodegenerative Disorders With These AgentsMaria-Christina Sioufi, Isabela Heroiu, Sabrina Wong, et al.Journal of Psychiatric Research|January 16, 2025
Trauma exposure as a risk factor of major depressive disorder: A matched case-control studyWenjian Lai, Huimin Zhang, Yingchen Jiang, et al.Expert Opinion on Pharmacotherapy|March 22, 2024
Efficacy, safety, and tolerability of xanomeline for schizophrenia spectrum disorders: a systematic reviewAlexia Leber, Ranuk Ramachandra, Felicia Ceban, et al.Pageof 16